The award will help Gokel and his group, Upaya Pharmaceuticals, progress their antibiotic resistance technology along the path toward commercialization.
The award will help Gokel and his group, Upaya Pharmaceuticals, progress their antibiotic resistance technology along the path toward commercialization.
The award will help Gokel and his group, Upaya Pharmaceuticals, progress their antibiotic resistance technology along the path toward commercialization.
The award will help Gokel and his group, Upaya Pharmaceuticals, progress their antibiotic resistance technology along the path toward commercialization.
Rohlfing is continuing to work in Assistant Professor Azim Ahmadzadeh’s lab conducting research on solar flares after finishing the accelerated master’s program in December.